Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Down – Here’s What Happened

Ono Pharmaceutical Co. (OTCMKTS:OPHLF)’s share price gapped down before the market opened on Thursday. The stock had previously closed at $15.16, but opened at $14.10. Ono Pharmaceutical shares last traded at $14.10, with a volume of 1,000 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research lowered Ono Pharmaceutical from a “strong-buy” rating to a “hold” rating in a research note on Friday, September 4th. One research analyst has rated the stock with a Hold rating. According to data from MarketBeat, Ono Pharmaceutical has a consensus rating of “Hold”.

Ono Pharmaceutical Stock Performance

The firm has a market cap of $6.63 billion, a price-to-earnings ratio of 13.43 and a beta of 0.38. The company has a current ratio of 3.28, a quick ratio of 2.86 and a debt-to-equity ratio of 0.08. The stock’s 50 day moving average is $15.21 and its 200 day moving average is $14.87.

About Ono Pharmaceutical

Ono Pharmaceutical Co, Ltd. is a Japan-based research-driven pharmaceutical company focused on discovering, developing and commercializing prescription medicines. Its primary therapeutic areas include oncology, immunology, neurology and other specialty-care fields. The company develops medicines internally and also works with research institutions and global pharmaceutical partners.

Ono is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used in the treatment of multiple types of cancer.